Design, synthesis, and biological evaluation of 2,4-diamino-5-methyl-6- substituted-pyrrolo[2,3-d]pyrimidines as dihydrofolate reductase inhibitors

Aleem Gangjee, Xin Lin, Sherry F. Queener

Research output: Contribution to journalArticle

36 Scopus citations

Abstract

2,4-Diamino-5-methyl-6-(substituted-phenyl)thiopyrrolo[2,3-d]pyrimidines 4-11 were synthesized as dihydrofolate reductase (DHFR) inhibitors against opportunistic pathogens that afflict patients with AIDS. Synthesis was achieved from 2,4-diamino-5-methypyrrolo[2,3-d]pyrimidine and substituted phenylthiols under modified conditions reported by Gangiee et al. Some of these compounds were potent and selective against DHFR from both Toxoplasma gondii and Mycobacterium avium compared to mammalian DHFR. Compound 11 with a 1-naphthyl substituent is 16-fold more potent and equally selective against Toxoplasma gondii DHFR as the clinically used trimethoprim.

Original languageEnglish (US)
Pages (from-to)3689-3692
Number of pages4
JournalJournal of Medicinal Chemistry
Volume47
Issue number14
DOIs
StatePublished - Jul 1 2004

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Fingerprint Dive into the research topics of 'Design, synthesis, and biological evaluation of 2,4-diamino-5-methyl-6- substituted-pyrrolo[2,3-d]pyrimidines as dihydrofolate reductase inhibitors'. Together they form a unique fingerprint.

  • Cite this